The debacle facing NMN supplement brands reflects growing concerns over a drug "exclusion" provision in U.S. law that FDA concluded is applicable to β-NMN.
A Freedom of Information Act (FOIA) lawsuit recently filed by Judicial Watch (JW) is seeking abortion pill stability and manufacturing information from the U.S. Department of Health and Human Services (HHS), which oversees the U.S. Food and Drug Administration (FDA).
<p><i> 10 minutes </i></p><p>To build an IP litigation system with a higher level of professionalism, efficiency and consistency with international trends, the Judicial Yuan recently published a draft amendment to the Intellectual Property Case Adjudication Act, proposing a comprehensive review of the adjudication proceedings of IP cases. Covering a wide range of aspects, the draft represents an unprecedented revision to the Act since its implementation more than 14 years ago, and thus should be given particular attention.</p>